Page last updated: 2024-10-31

entinostat and Lymphoma, Primary Effusion

entinostat has been researched along with Lymphoma, Primary Effusion in 1 studies

Lymphoma, Primary Effusion: A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.

Research Excerpts

ExcerptRelevanceReference
" Importantly, in vivo preclinical studies showed that 009P1 and 009P2 dramatically suppressed KSHV+ lymphoma progression with oral bioavailability and minimal visible toxicity."1.91Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas. ( Chen, J; Chen, Z; Dai, L; Kendrick, S; Li, HY; Lin, Z; Phuc, T; Qin, Z; Wang, Z; Xu, Z; Yang, D, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J1
Wang, Z1
Phuc, T1
Xu, Z1
Yang, D1
Chen, Z1
Lin, Z1
Kendrick, S1
Dai, L1
Li, HY1
Qin, Z1

Other Studies

1 other study available for entinostat and Lymphoma, Primary Effusion

ArticleYear
Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas.
    PLoS pathogens, 2023, Volume: 19, Issue:1

    Topics: Cell Cycle Proteins; Cell Line, Tumor; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; Humans;

2023